R. Sechaud

发表

CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS LEADS TO BETTER RENAL FUNCTION AND TO PROFOUND CHANGES IN EVEROLIMUS AND MYCOPHENOLATE METABOLISM

K. Budde, W. Arns, P. Glander, 2006 .

Estimation of glomerular filtration rate by sinistrin clearance using various approaches.

T. Buclin, J. Biollaz, L. Decosterd, 1998, Renal failure.

Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection.

M. Rouan, P. Mangoni, G. Maurer, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD).

D. Renard, A. Drollmann, G. Kaiser, 2012, International journal of clinical pharmacology and therapeutics.

Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.

B. Bieth, H. Tillmann, I. Demin, 2016, International journal of clinical pharmacology and therapeutics.

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Y. Bertrand, R. Galanello, A. Piga, 2006 .

Extrapancreatic effect of glibenclamide: Stimulation of duodenal insulin-releasing activity (DIRA) in man

J. Felber, A. Zermatten, W. Heptner, 1977, Diabetologia.

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.

R. Galanello, A. Piga, M. Rouan, 2003, Journal of clinical pharmacology.

Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen

J. Ford, M. Cappellini, R. Galanello, 2008, Journal of clinical pharmacology.

Pharmacokinetics and variability of mycophenolic acid from enteric‐coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

G. Gerosa, L. Miller, H. Ross, 2007, Clinical transplantation.

Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co‐administered enteric‐coated mycophenolate sodium

H. Meier‐Kriesche, B. Kaplan, R. Schmouder, 2005, Clinical transplantation.

Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State

G. Bruin, F. Waldmeier, J. Porter, 2010, Drug Metabolism and Disposition.

Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron‐Chelating Agent in Patients with Transfusion‐Dependent Iron Overload Due to β‐Thalassemia

R. Galanello, A. Piga, M. Rouan, 2003 .

Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects

A. Robeva, R. Belleli, R. Sechaud, 2008, Journal of clinical pharmacology.

Phase II clinical evaluation of deferasirox , a once-daily oral chelating agent , in pediatric patients with β-thalassemia major

Y. Bertrand, R. Galanello, A. Piga, 2006 .

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

J. Ford, M. Cappellini, R. Galanello, 2006, Haematologica.

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

E. Neufeld, N. Olivieri, R. Grady, 2003, The Lancet.

Preliminary Results from a Phase Ib Study Exploring MDM2 Inhibitor Siremadlin (HDM201) in Combination with B-Cell Lymphoma-2 (BCL-2) Inhibitor Venetoclax in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS)

Ensar Halilovic, A. Wei, K. Porkka, 2021, Blood.

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

S. Abdulla, C. Reynolds, G. Lefèvre, 2010, Malaria Journal.

Sinistrin Clearance for Determination of Glomerular Filtration Rate: A Reappraisal of Various Approaches Using a New Analytical Method

A. Munafo, T. Buclin, J. Biollaz, 1997, Journal of clinical pharmacology.

Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML)

T. Ouatas, K. Grosch, R. Sechaud, 2022, Cancer Chemotherapy and Pharmacology.

Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks.

E. Brun, F. Pommier, T. Dumortier, 2008, International journal of clinical pharmacology and therapeutics.

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Hung-Ming Wang, V. Lee, P. Lou, 2021, Clinical Cancer Research.

Determination of the polyfructosan sinistrin in biological fluids by HPLC with electrochemical detection.

J. Biollaz, L. Decosterd, U. Kesselring, 1996, Journal of pharmaceutical and biomedical analysis.

Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach.

Michael Looby, Christian Bartels, C. Bartels, 2013, British journal of clinical pharmacology.

Glycopyrronium does not affect QT interval in healthy subjects: a randomized, three- period, cross-over, placebo- and positive-controlled study.

P. Pal, A. Drollmann, S. Uziel-Fusi, 2013, International journal of clinical pharmacology and therapeutics.

Enteric-Coated Mycophenolate Sodium Provides Higher Mycophenolic Acid Predose Levels Compared With Mycophenolate Mofetil: Implications for Therapeutic Drug Monitoring

K. Budde, P. Glander, H. Neumayer, 2007, Therapeutic drug monitoring.

Pharmacokinetics of Glycopyrronium Following Repeated Once-Daily Inhalation in Healthy Chinese Subjects

H. Tillmann, S. Machineni, Shuang Ren, 2016, European Journal of Drug Metabolism and Pharmacokinetics.

Effect of dual bronchodilation with QVA149 on cardiac safety in healthy volunteers.

A. Drollmann, I. Jones, S. Febbraro, 2014, International journal of clinical pharmacology and therapeutics.

[The value of colonoscopy].

R. Sechaud, 1983, Revue medicale de la Suisse romande.

J. Rawls, J. Campestrini, R. Sechaud, 2000 .

Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.

M. Merz, M. Letzkus, E. Gruendl, 2002, International journal of clinical pharmacology and therapeutics.